Publicaciones seleccionadas

    Li G, Chen T, Dahlman J, Eniola-Adefeso L, Ghiran IC, Kurre P, Lam WA, Lang JK, Marbán E, Martín P, Momma S, Moos M, Nelson DJ, Raffai RL, Ren X, Sluijter JPG, Stott SL, Vunjak-Novakovic G, Walker ND, Wang Z, Witwer KW, Yang PC, Lundberg MS, Ochocinska MJ, Wong R, Zhou G, Chan SY, Das S, Sundd P. Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases. J Extracell Vesicles (2023) 12:e12305
    Link to the full text in Repisalud
    Heidecker B, Dagan N, Balicer R, Eriksson U, Rosano G, Coats A, Tschöpe C, Kelle S, Poland GA, Frustaci A, Klingel K, Martin P, Hare JM, Cooper LT, Pantazis A, Imazio M, Prasad S, Lüscher TF Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases Eur J Heart Fail (2022) 6
    Link to the full text in Repisalud
    Blanco-Domínguez R, de la Fuente H, Rodríguez C, Martín-Aguado L, Sánchez-Díaz R, Jiménez-Alejandre R, Rodriguez-Arabaolaza I, Curtabbi A, Garcia-Guimaraes MM, Vera A, Rivero F, Cuesta J, Jimenez-Borreguero LJ, Cecconi A, Duran-Cambra A, Taurón M, Alonso J, Bueno H, Villalba-Orero M, Enriquez JA, Robson SC, Alfonso F, Sánchez-Madrid F, Martínez-González J, Martín P. CD69 expression on regulatory T cells protects from immune damage after myocardial infarction. J Clin Invest (2022) 132:75-75
    Repisalud
    Fernández-Gallego N, Castillo-González R, Méndez-Barbero N, Sanz C, L, Obeso D, Villaseñor A, Escribese M, López-Melgar B, Salamanca J, Benedicto-Buendía A, Jiménez-Borreguero L, J, Ibañez B, Sastre J, Belver M, Vega F, Blanco C, Hernández D, B, Sánchez-Madrid F, Fuente H de la, Martin P, Esteban V, Jimenez-Saiz R, The impact of type 2 immunity and allergic diseases in atherosclerosis ALLERGY (2022) 77:3249-3266
    Link to the full text in Repisalud
    Cecconi A, Navarrete G, Garcia-Guimaraes M, Vera A, Blanco-Dominguez R, Sanz-Garcia A, Lozano-Prieto M, Lopez-Melgar B, Rivero F, Martin P, Sanchez-Madrid F, de la Fuente H, Jimenez-Borreguero LJ, Alfonso F. Influence of air pollutants on circulating inflammatory cells and microRNA expression in acute myocardial infarction Sci Rep (2022) 12:5350
    Link to the full text in Repisalud
    Jiménez-Alejandre R, Ruiz-Fernández I, Martín P. Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis. Cancers (Basel) (2022) 14:4494
    Repisalud
    Blanco-Domínguez R, Sánchez-Díaz R, de la Fuente H, Jiménez-Borreguero LJ, Matesanz-Marín A, Relaño M, Jiménez-Alejandre R, Linillos-Pradillo B, Tsilingiri K, Martín-Mariscal ML, Alonso-Herranz L, Moreno G, Martín-Asenjo R, García-Guimaraes MM, Bruno KA, Dauden E, González-Álvaro I, Villar-Guimerans LM, Martínez-León A, Salvador-Garicano AM, Michelhaugh SA, Ibrahim NE, Januzzi JL, Kottwitz J, Iliceto S, Plebani M, Basso C, Baritussio A, Seguso M, Marcolongo R, Ricote M, Fairweather D, Bueno H, Fernández-Friera L, Alfonso F, Caforio ALP, Pascual-Figal DA, Heidecker B, Lüscher TF, Das S, Fuster V, Ibáñez B, Sánchez-Madrid F, Martín P A Novel Circulating MicroRNA for the Detection of Acute Myocarditis N Engl J Med (2021) 384:2014-27
    Link to the full text in Repisalud
    Lozano-Prieto M, Adlam D, García-Guimaraes M, Sanz-García A, Vera-Tomé P, Rivero F, Cuesta J, Bastante T, Baranowska-Clarke AA, Vara A, Martin-Gayo E, Vicente-Manzanares M, Martin P, Samani NJ, Sánchez-Madrid F, Alfonso F, de la Fuente H Differential miRNAs in acute spontaneous coronary artery dissection: Pathophysiological insights from a potential biomarker EBioMedicine (2021) 66:103338
    Rello P, Garcia Del Blanco B, Ruiz-Meana M, Miro-Casas E, Alfonso F, Garcia-Picart J, Barrabes JA, Borras G, Martin P, Dorado DG, Sambola A Differential features in composition of coronary thrombus of women with ST-segment elevation myocardial infarction Thromb Res (2020) 186:64-70
    Link to the full text in Repisalud
    Martin P, Blanco-Dominguez R, Sanchez-Diaz R Novel human immunomodulatory T cell receptors and their double-edged potential in autoimmunity, cardiovascular disease and cancer Cell Mol Immunol (2020) 18:919-35
    Tsilingiri K, de la Fuente H, Relano M, Sanchez-Diaz R, Rodriguez C, Crespo J, Sanchez-Cabo F, Dopazo A, Alonso-Lebrero JL, Vara A, Vazquez J, Casasnovas JM, Alfonso F, Ibanez B, Fuster V, Martinez-Gonzalez J, Martin P*, Sanchez-Madrid F*. (PM and FSM are co-corresponding authors) oxLDL Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease. Circulation (2019) 139:243-55
    Link to the full text in Repisalud
    Sánchez-Díaz R, Blanco-Dominguez R, Lasarte S, Tsilingiri K, Martín-Gayo E, Linillos-Pradillo B, de la Fuente H, Sánchez-Madrid F, Nakagawa R, Toribio ML, Martín P. Thymus-derived Treg cell development is regulated by C-type-lectin–mediated BIC/miRNA155 expression. Mol Cell Biol (2017) 37:e00341-16
    Link to the full text in Repisalud
    Cibrian D, Saiz ML, de la Fuente H, Sanchez-Diaz R, Moreno-Gonzalo O, Jorge I, Ferrarini A, Vazquez J, Punzon C, Fresno M, Vicente-Manzanares M, Dauden E, Fernandez-Salguero PM, Martin P, Sanchez-Madrid F. CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis. Nat Immunol (2016) 17:985-96
    Liappas G*, Gonzalez-Mateo GT*, Sanchez-Diaz R*, Lazcano JJ, Lasarte S, Matesanz-Marin A, Zur R, Ferrantelli E, Ramirez LG, Aguilera A, Fernandez-Ruiz E, Beelen RH, Selgas R, Sanchez-Madrid F, Martin P*, Lopez-Cabrera M*. (GL, GTGM and RSD contributed equally and PM and MLC are co-corresponding authors) Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis. J Am Soc Nephrol (2016) 27:3561-76
    Fabbiano S, Menacho-Marquez M, Robles-Valero J, Pericacho M, Matesanz-Marin A, Garcia-Macias C, Sevilla MA, Montero MJ, Alarcon B, Lopez-Novoa JM, Martin P, Bustelo XR. Immunosuppression-Independent Role of Regulatory T Cells against Hypertension-Driven Renal Dysfunctions. Mol Cell Biol (2015) 35:3528-46
    Cortes JR*, Sanchez-Diaz R*, Bovolenta ER, Barreiro O, Lasarte S, Matesanz-Marin A, Toribio ML, Sanchez-Madrid F, Martin P (JRC and RSD contributed equally) Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expresion J Autoimmun (2014) 55C:51-62
    González-Amaro R, Cortés JR, Sánchez-Madrid F, Martín P. Is CD69 an effective brake to control inflammatory diseases? Trends Mol Med (2013) 19:625-32
    Martín P, Sánchez-Madrid F. CD69: An Unexpected Regulator of TH17 Cell-Driven Inflammatory Responses. Science Signaling (2011) 4:pe14
    Cruz-Adalia A, Jiménez-Borreguero LJ, Ramírez-Huesca M, Chico-Calero I, Barreiro O, López-Conesa E, Fresno M, Sánchez-Madrid F, Martín P. CD69 Limits the Severity of Cardiomyopathy After Autoimmune Myocarditis. Circulation (2010) 122:1396-404
    Martín P, Gómez M, Lamana A, Cruz-Adalia A, Ramírez-Huesca M, Ursa MA, Yáñez-Mo M, Sánchez-Madrid F. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation. Mol Cell Biol (2010) 30:4877-89

    - 20 -

    Ver todas las publicaciones CNIC »